Kearny Venture Partners is a venture capital firm that focuses its investments on healthcare companies that produces novel therapies.
With over $330 million in capital under management, Kearny Venture Partners is a venture capital firm exclusively focused on healthcare products. We believe that the opportunity for entrepreneurs to devise innovative solutions in healthcare has never been greater. Significant unmet needs in healthcare continue to persist, representing large potential market opportunities for safe and effective products. As the molecular basis of disease is increasingly unraveled, new opportunities for intervention emerge. Novel therapies can and will displace incumbent products.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Jan 18, 2017
ViewRay
|
Post-IPO Equity | $26.10M | Biotechnology | — |
Aug 22, 2016
ViewRay
|
Post-IPO Equity | $14M | Biotechnology | Yes |
Jul 24, 2015
ViewRay
|
Post-IPO Equity | $26.70M | Biotechnology | — |
Dec 17, 2013
ViewRay
|
Series Unknown | $30M | Biotechnology | — |
May 21, 2013
ViewRay
|
Series Unknown | $15M | Biotechnology | — |